Biomarker Development for Muscular Dystrophies — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Biomarker Development for Muscular Dystrophies — Stella

Home/Myotonic Dystrophy/

View on ClinicalTrials.gov

Recruiting

Back to Myotonic Dystrophy trials

Trial locations(5 sites)

United States

Boston Children's Hospital, Boston, Massachusetts

Brigham and Women's Hospital, Boston, Massachusetts

Massachusetts General Hospital, Boston, Massachusetts

Wake Forest University, Winston-Salem, North Carolina

University of Pittsburgh, Pittsburgh, Pennsylvania

Key details

Sponsor

Massachusetts General Hospital

Collaborators

Boston Children's Hospital, Wake Forest University

Enrollment target

~465 participants

Started

February 2015

Primary completion

June 2027

Age range

5 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.